Conditions

The Type 1 Diabetes Grand Challenge

The Novel insulins Innovation Incubator call from the Type 1 Diabetes Grand Challenge is designed to support transformative research in the field of insulin development. This funding call is open to academic groups and small to medium size biotechnology and pharmaceutical companies without geographical restrictions.
Award programme/theme
Project grant
Funding amount range
£250,001 to £500,000
Maximum duration
1 year
Submission deadline

JDRF - Glycaemic and beta cell monitoring in individuals at risk of type 1 diabetes

The aim of this call is advancing our understanding of glycaemic changes during disease progression in presymptomatic individuals (Stages 1 and 2), with the potential to improve progression biomarkers and monitoring their transition to clinical diagnosis (Stage 3). The focus of this call is the improvement of current or new metabolic risk assessment tools and their integration into clinically and commercially utilized testing platforms.
Award programme/theme
Project grant
Funding amount range
Over £500,000
Maximum duration
3 years
Submission deadline
News

RCPCH responds to Government’s review of on 20mph limits and low traffic neighbourhoods in England

The Government has recently set out a strategy in which they will review the guidance on 20mph limits and low traffic neighbourhoods in England. Reports now say that the Government is preparing to stop English councils from introducing new 20mph speed limits.
News

Epilepsy12 Youth Advocates awarded the Patient and Public Involvement Hero Award by HQIP

On 20 June 2023, the Epilepsy12 Youth Advocates were announced as joint winners of the Patient and Public Involvement Hero Award by the Healthcare Quality Improvement Partnership (HQIP). The award is one of five Clinical Audit Heroes Awards that are announced during the 2023 Clinical Audit Awareness...